F. Ventura

Current pharmacotherapeutic options for primary dyslipidemia in adults

C. Borghi, A. Cicero, M. Landolfo, 2019, Expert opinion on pharmacotherapy.

Diabetes in the third millennium: prognosis improves, but juvenile forms are more frequent

C. Borghi, F. Ventura, Fulvio Ventura, 2019, European heart journal supplements : journal of the European Society of Cardiology.

Decrease mortality in type II diabetes mellitus: glycemic and renal function control

C. Borghi, F. Ventura, 2018, Journal of cardiovascular medicine.

Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study

A. D'Angelo, G. Derosa, C. Borghi, 2022, Biomedicines.

Awareness of major cardiovascular risk factors and its relationship with markers of vascular aging: Data from the Brisighella Heart Study.

G. Tocci, C. Borghi, F. Fogacci, 2020, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Optimizing Lipid Pattern by Adding a Combined Nutraceutical or Pravastatin to Fenofibrate Treatment in Hypertriglyceridemic Subjects: Single Site, Randomized, Open-Label, Post-Market Clinical Investigation

C. Borghi, F. Fogacci, A. Cicero, 2018, High Blood Pressure & Cardiovascular Prevention.

Evaluation of twelve formulas for LDL-C estimation in a large, blinded, random Italian population.

R. Mancini, C. Borghi, A. Cicero, 2021, International journal of cardiology.